Management of Allergic Rhinitis Unresponsive to Standard‑Dose Cetirizine

1. Initial Therapeutic Options

When symptoms do not improve on standard‑dose cetirizine, either increase cetirine to a maximum of 20 mg daily (if sedation is acceptable) or switch to fexofenadine 180 mg once daily as the preferred first‑line alternative. 1

Dose escalation of cetirizine up to 20 mg daily can be considered before changing agents, provided the patient tolerates potential sedation. 1

Fexofenadine 180 mg once daily maintains a completely non‑sedating profile even at higher doses, making it ideal for patients who need to drive, operate machinery, or are elderly. 2

Desloratadine 5 mg daily provides superior decongestant activity and anti‑inflammatory effects compared with loratadine, useful when nasal congestion is prominent. 2

Loratadine is non‑sedating at recommended doses and is less expensive, offering a cost‑effective option when budget is a concern. 2

Levocetirizine 5 mg daily has efficacy comparable to cetirizine but shares a similar sedation risk, making it less suitable if sedation was problematic with cetirine. 2
Levocetirizine may confer additional benefit in patients with co‑existing asthma, improving both upper and lower airway symptoms. 4

Intranasal corticosteroids are more effective than antihistamines alone for controlling the full spectrum of allergic rhinitis symptoms, especially nasal congestion. 2
Combining an intranasal corticosteroid with any second‑generation antihistamine yields superior symptom relief compared with either therapy used in isolation. 2

Ciclosporin 4 mg/kg daily for up to 16 weeks achieves symptom control in roughly two‑thirds of patients with severe autoimmune urticaria unresponsive to high‑dose antihistamines. 3
Additional options such as omalizumab, plasmapheresis, or intravenous immunoglobulin are available but are costly and not widely accessible. 3

Not all second‑generation antihistamines are equally non‑sedating; cetirizine and levocetirizine can cause meaningful sedation, whereas fexofenadine does not. 2
Antihistamines have limited efficacy for nasal congestion; patients whose primary complaint is congestion should receive an intranasal corticosteroid or appropriate decongestant. 2
Continuous daily antihistamine therapy is more effective than intermittent use for seasonal or perennial allergic rhinitis due to ongoing allergen exposure. 2
Renal dose adjustments are essential: cetirizine requires a 50 % dose reduction in moderate renal impairment and should be avoided in severe impairment, while fexofenadine does not require adjustment. 1
Performance impairment can occur with cetirizine even in the absence of perceived drowsiness, potentially affecting safety in tasks requiring alertness. 2

Elderly patients: Prefer fexofenadine to minimize fall risk and cognitive impairment associated with sedating antihistamines. 2
Pregnancy: Avoid antihistamines in the first trimester when possible; cetirizine (FDA Category B) is acceptable if treatment is necessary. 1
Renal impairment: Choose fexofenadine as it does not require dose modification, unlike cetirizine which needs adjustment. 1